Cancer & Metabolism

Papers
(The H4-Index of Cancer & Metabolism is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition80
The classification of obesity based on metabolic status redefines the readmission of non-Hodgkin’s lymphoma—an observational study58
A role of arginase-1-expressing myeloid cells in cachexia38
GCN2-SLC7A11 axis coordinates autophagy, cell cycle and apoptosis and regulates cell growth in retinoblastoma upon arginine deprivation34
FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma34
Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells33
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival32
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma29
Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response29
Autofluorescence imaging of endogenous metabolic cofactors in response to cytokine stimulation of classically activated macrophages25
Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells24
Circulating metabolome landscape in Lynch syndrome22
Glycemic status, insulin resistance, and mortality from lung cancer among individuals with and without diabetes20
Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells20
Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer19
Steatohepatitis-induced vascular niche alterations promote melanoma metastasis19
Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress19
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors18
0.019071817398071